Previous studies have indicated different abnormalities of PRL secreti
on in patients with primary empty sella (PES). Since it is known that
endogenous opiates and dopamine interact in modulating PRL secretion,
we have studied the effect of an opiate receptor blockade (with Naloxo
ne, NAL, 1.6 mg/h as a continuous infusion) on anterior pituitary horm
ones and on PRL responsiveness to metoclopramide (MCP), in 10 premenop
ausal normoprolactinemic patients with PES, studied in follicular phas
e, in order to investigate neurotransmitter abnormalities present in s
uch a syndrome. NAL failed to significantly affect LH and FSH basal le
vels; on the contrary, slight but significant increases in PRL and GH
secretion were observed. NAL partially blunted the PRL responsiveness
to the dopaminergic blockade, which was very marked when tested after
MCP alone. These data confirm that the modulation of anterior pituitar
y hormone secretion is different in PES patients, when compared with n
ormal subjects. The infusion of NAL induced a ''paradoxical'' increase
in hormones (PRL and GH) which are normally stimulated by endogenous
opiates; but, on the other side, it blocked the marked PRL responsiven
ess to the dopaminergic blockade, which is characteristic of PES syndr
ome. This phenomenon seems to indicate that the relationships between
dopaminergic and opiatergic neurons could be modified by the neuroanat
omic alteration which is present in this complex syndrome.